SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056793
Filing Date
2021-11-15
Accepted
2021-11-15 06:21:54
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q Q1 FY 2022 ktra-10q_20210930.htm   iXBRL 10-Q 2310920
2 EX-31.1 ktra-ex311_7.htm EX-31.1 21567
3 EX-31.2 ktra-ex312_8.htm EX-31.2 21278
4 EX-32.1 ktra-ex321_9.htm EX-32.1 8851
5 EX-32.2 ktra-ex322_6.htm EX-32.2 8895
6 GRAPHIC gcjkgpkzehjv000002.jpg GRAPHIC 40295
7 GRAPHIC gcjkgpkzehjv000001.jpg GRAPHIC 67724
  Complete submission text file 0001564590-21-056793.txt   8885742

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA ktra-20210930.xsd EX-101.SCH 72730
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ktra-20210930_cal.xml EX-101.CAL 27101
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ktra-20210930_def.xml EX-101.DEF 245781
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ktra-20210930_lab.xml EX-101.LAB 459647
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ktra-20210930_pre.xml EX-101.PRE 362776
13 EXTRACTED XBRL INSTANCE DOCUMENT ktra-10q_20210930_htm.xml XML 1699559
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37823 | Film No.: 211406140
SIC: 2834 Pharmaceutical Preparations